Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 25.18
-0.11 (-0.43%)
Sep 4, 2026, 3:00 PM CST
SHA:688321 Market Cap
SHA:688321 has a market cap or net worth of 11.14 billion as of September 4, 2026. Its market cap has decreased by -26.36% in one year.
Market Cap
11.14B
Enterprise Value
11.17B
Revenue
1.05B
Ranking
n/a
PE Ratio
114.25
Stock Price
25.18
ChartMarket Cap Chart
Since August 12, 2019, SHA:688321's market cap has decreased from 39.08B to 11.14B, a decrease of -71.50%. That is a compound annual growth rate of -16.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 11.14B | -6.53% |
| Dec 31, 2025 | 11.92B | 57.27% |
| Dec 31, 2024 | 7.58B | -15.30% |
| Dec 29, 2023 | 8.95B | - |
| Dec 30, 2022 | 8.95B | -37.79% |
| Dec 31, 2021 | 14.38B | -5.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.12B |
| Guobang Pharma | 12.03B |
| Wedge Industrial | 12.02B |
| Zhejiang Medicine | 12.02B |
| Shanghai Shyndec Pharmaceutical | 11.39B |
| Zhejiang CONBA Pharmaceutical | 11.14B |
| Henan Lingrui Pharmaceutical | 11.12B |
| Beijing Aosaikang Pharmaceutical | 10.86B |